Trevi Therapeutics, Inc. TRVI Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s software and technology licenses, net?
- Trevi Therapeutics, Inc. (TRVI) reported software and technology licenses, net of $2.61M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Trevi Therapeutics, Inc.'s software and technology licenses, net increased by 983.0% year-over-year, from $241K to $2.61M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s software and technology licenses, net has grown at a 11.8% compound annual growth rate (CAGR), from $532K to $928K.